reversed-phase HPLC comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2025-09-04. Numbers and descriptions here follow the published literature rather than marketing material.
Quality control for thymosin alpha-1 focuses on identity, purity, and potency. Identity is confirmed by mass spectrometry and amino acid analysis, while purity is assessed by chromatography with limits on related substances and residual solvents. Potency assays may use cell-based immune readouts, but these are not standardized across laboratories. Regulatory status differs by jurisdiction; no product is approved in the United States for clinical use, whereas some other countries register injectable forms for specific indications.
Quantifying thymosin alpha-1 in a sample usually relies on reverse-phase high-performance liquid chromatography. The peptide lacks strong chromophores, so detection often occurs at 214 nm, where the peptide backbone absorbs. Mass spectrometry provides confirmatory identification and can detect sequence variants or truncations. Immunoassays have been used in biological matrices, but they may cross-react with related fragments. For purity assessment, chromatographic peak area gives the main component percentage, while mass accuracy verifies molecular identity.
The lyophilized peptide is generally stable for extended periods when kept cold and dry. Once dissolved, aqueous solutions are less stable; hydrolysis, oxidation, and aggregation can degrade the material. Storage at -20 °C or lower slows these processes. Repeated freeze-thaw cycles are best avoided because they can promote aggregation. The exact shelf life depends on formulation, pH, and concentration, so stability studies are typically performed for each specific product.
Most published studies on thymosin alpha-1 report changes in immune measurements rather than clinical outcomes, and findings differ across designs and populations. Whether the peptide signals through one defined receptor or through several less specific interactions remains an open question. Its reported circulation half-life of a few hours complicates comparison of dosing schedules across trials. Mechanistic claims are frequently drawn from isolated cell cultures, and how far those results extend to whole organisms is unresolved.
Thymosin alpha-1 is a synthetic peptide of 28 amino acids whose sequence matches the amino-terminal region of prothymosin alpha. The chain is acetylated at its first residue and contains one disulfide bridge between two cysteine residues, which folds the molecule into a compact loop. Its molecular formula, C129H215N33O55, corresponds to a monoisotopic mass of roughly 3,106 daltons. Material used in laboratories is made by solid-phase synthesis rather than isolated from animal tissue.
Early work on thymic extracts in the 1960s described a heat-stable acidic fraction containing many polypeptides. Separation of that mixture yielded individual components, and thymosin alpha-1 was named as one of them on the basis of assays for T-cell activity. The first preparations came from calf thymus, while subsequent research and clinical material has been chemically synthesized. Nomenclature in older papers is inconsistent, and the same peptide sometimes appears under different designations, which complicates literature searches.
| Property | Value | Notes |
|---|---|---|
| Detection wavelength | 214 nm | Peptide bond absorption; 280 nm is not useful. |
| Confirmatory method | Electrospray mass spectrometry | Verifies mass near 3108 Da. |
| Solution stability | Limited at room temperature | Aqueous solutions degrade faster than powder. |
| Recommended storage | -20 °C | For lyophilized powder; protect from moisture. |
| Purity criterion | ≥95% by RP-HPLC | Typical research-grade specification. |
临床研究将Tα1用于慢性病毒感染、肿瘤辅助治疗和疫苗佐剂等场景。部分试验报告了免疫学指标改善，但临床终点获益在不同研究中并不一致。系统综述指出，研究间在人群、剂量和联合方案上差异较大，难以汇总结论。因此，Tα1的确切临床地位仍属开放问题，需要更多高质量随机对照试验来澄清。其机制研究也需从体外实验向体内模型推进。
胸腺素α1对免疫系统的影响涉及多种细胞类型。研究表明，它可促进未成熟T细胞向成熟T细胞分化，并增强T细胞对抗原刺激的增殖反应。树突状细胞在Tα1存在下表达更高水平的共刺激分子，从而更有效地呈递抗原。此外，自然杀伤细胞的活性也观察到上升。这些效应并非直接杀伤病原体，而是调节宿主免疫应答的强度与方向。
在信号层面，Tα1可能通过Toll样受体等模式识别受体发挥作用。部分实验显示，它能激活髓样分化因子88依赖的通路，进而促进核因子κB进入细胞核。这导致白细胞介素2、干扰素γ和白细胞介素12等细胞因子的转录增加。这些细胞因子偏向辅助性T细胞1型应答，有助于细胞免疫。然而，具体受体和结合位点尚未完全确定，不同实验模型的结果存在差异。
The peptide is generated in cells by cleavage of prothymosin alpha, a larger acidic protein encoded by the PTMA gene. Prothymosin alpha is expressed in many tissues, not only in the thymus, and its functions include nuclear roles in chromatin-related processes. The 28-residue fragment corresponds to the N-terminal portion of that precursor. How the cleavage occurs and how the fragment's concentration is regulated remain open questions; circulating amounts are small and difficult to measure reliably with routine assays.
Thymosin alpha 1 is a short peptide first isolated from bovine thymus tissue in the early 1970s during fractionation work aimed at identifying factors that influence T cell development. It belongs to a family of acidic thymic peptides, and the original preparations contained several components that were later separated by chromatography. The compound is now produced synthetically rather than extracted from tissue, which removes batch variability tied to animal sourcing. Researchers describe it as an immunomodulatory peptide because laboratory studies show effects on several cell types of the innate and adaptive immune systems.
The molecule consists of 28 amino acid residues with an acetyl group attached to the N-terminal serine. Its sequence is acidic overall, with several glutamic and aspartic acid residues distributed along the chain and no cysteine, so disulfide bridges do not form. The peptide carries a net negative charge at physiological pH. Because the N-terminus is blocked, the intact molecule resists degradation by many aminopeptidases, which contributes to its stability in biological fluids.
Storage recommendations center on low temperature, dryness, and protection from repeated freezing and thawing. The intact powder is commonly held at 20 degrees below zero Celsius or colder, while a working solution is divided into single-use aliquots to limit freeze-thaw cycles. Buffered saline or phosphate-buffered saline at neutral pH is frequently used as a diluent. Light sensitivity is not well documented, yet amber vials or foil wrapping are common practice for long-term storage of peptide stocks.
Identity and purity are assessed with a small set of standard peptide methods. Reversed-phase high-performance liquid chromatography separates the main peak from truncated or oxidized species, and its area percentage is the usual purity measure. Mass spectrometry confirms the observed molecular mass against the expected value, while amino acid analysis or peptide mapping checks composition and sequence. Specifications for research-grade material are often stated as 95 percent or higher, though the exact limit depends on the supplier and the intended use.
Laboratory supplies of the peptide usually arrive as a lyophilized powder in sealed vials. The powder is hygroscopic, so a vial should be allowed to reach room temperature before it is opened to prevent condensation on the contents. Weighing and transfer are best performed in a low-humidity environment with clean tools. Once dissolved, the solution should be mixed gently rather than vortexed, because foaming and shear can reduce recovery of the peptide.
Thymosin alpha 1 was identified in 1977 as a component of thymosin fraction 5, a heterogeneous preparation used in early studies of thymic function. Investigators purified the active material and determined its amino acid sequence, which enabled chemical synthesis. Work in the following decades concentrated on T-cell maturation and immune reconstitution in animals and small human cohorts. Early preparations varied in composition, so results from that period are difficult to compare with studies using defined synthetic peptide.
Clinical research has examined the peptide in chronic hepatitis B and C, as a vaccine adjuvant, and in sepsis and oncology settings. Findings across trials are mixed; some report changes in selected immune markers, while others find no clear clinical benefit. Many studies are small and define outcomes differently, which limits comparison. Regulatory approval is confined to a few countries, and the compound is not an approved drug in the United States or most of Europe.
=== EC 1.10.99 With unknown physiological acceptors === EC 1.10.99.1: Now EC 1.10.9.1 plastoquinol—plastocyanin reductase EC 1.10.99.2: Now EC 1.10.5.1 ribosyldihydronicotinamide dehydrogenase (quinone) EC 1.10.99.3: Now EC 1.23.5.1 violaxanthin de-epoxidase
In 2002, Applied Biosystems reached revenues of US$1.6 billion for the year, and took control from Celera of the support of Celera Discovery System (CDS), a data tool to answer specific genomic and proteomic queries, involving the new genetic data field of tens of thousands of single-nucleotide polymorphisms (SNPs) within the human genome. The company developed another new tool, which combined the first ever union of triple quadrupole and ion trap technologies, in proteomics research. The database itself would remain with Celera, because of shareholder approval complications. Celera would retain responsibility for its maintenance and support to existing customers, and would receive royalties from Applied Biosystems. In 2003, Catherine Burzik joined Applied's management, from Ortho-Clinical Diagnostics. Applied developed a new tool which measured antibody/antigen binding in real-time kinetic analysis of up to 400 binding interactions simultaneously. In 2004, Mike Hunkapiller retired and Cathy Burzik replaced him as President of Applied Biosystems. Applera collaborated with General Electric, Abbott Laboratories, Seattle Genetics, and Merck in diagnostics development. Applied Biosystmes also teamed with Northrop Grumman and Cepheid of Sunnyvale, California, to detect Bacillus anthracis during the anthrax contamination case of the U.S. Postal Service. In 2005, the company released new tools for small molecule quantitation in pharmaceutical drug development.
== Pharmacokinetics == The metabolism of topically applied nitrofurazone is thought to be by 5-nitro reduction and cleavage of the -CH=N- linkage to generate a reactive species which can covalently bond to cellular macromolecules, none of the end products are thought to be antimicrobial.
) the proton lifetimes results to be far too short. To forbid these operators, a new symmetry has to be imposed: the R-parity. This symmetry also stabilizes the lightest supersymmetric particle as a dark matter candidate.
==== Aqueous solutions ==== Aqueous solutions are solutions of a compound with water. In contrast to other formulations, such as oil solutions, aqueous suspensions, and emulsions, aqueous solutions of estradiol and estradiol esters by intramuscular injection are not depot injections. Instead, they are rapidly absorbed and eliminated, analogously to intravenous injections of estradiol and estradiol esters. The durations of aqueous solutions of estradiol and estradiol esters by intramuscular injection are measured in hours.
Sources: en.wikipedia.org
Another important element of the political crisis was the spectacular growth of independentism in Catalonia following the publication in late June 2010 of the Sentence of the Constitutional Court on the Statute of Autonomy of Catalonia of 2006, which after four years of deliberations dealt a severe blow to the aspirations of Catalan nationalism. On July 9, 2010, there was a big demonstration of rejection to the sentence with the slogan Som una nació, nosaltres decidim, which resulted in a plebiscite in favor of independence. Four months later, the Catalan Parliament elections were held, which were won by CiU and its leader Artur Mas was invested as the new president of the Generalitat. The change of government in Euskadi after the 2009 Basque Parliament elections — the Socialist Patxi López replaced the peneuvist Juan José Ibarretxe — the departure from the institutions of the groups inherited from Batasuna and the effectiveness of the security forces and corps in the fight against ETA – in less than two years, all the members of the leadership that had imposed in 2007 the breaking of the truce were arrested – among other reasons, forced the nationalist left to rethink its political strategy. Thus, in February 2010, Batasuna presented a first document in which it supported a "democratic process in the absence of violence", which was followed by the denominated "Brussels Declaration" in which an international intermediary group headed by the South African lawyer Brian Currin called on ETA to declare a permanent ceasefire.
=== Cancer === Depending on the type of cancer presented and the context, galectin-7 can either be helpful to suppress cancer or promote the cancer. What is suppressive of one tissue, such as the stomach, may be promotive in another, such as breast cancer or in the oral epithelium. It can up regulate by p53, making it a part of the pro-apoptotic network, however this can still be part of a promoter of tumors if apoptosis goes unregulated. P53 status is noted in cancers because of the chance for a mutant p53 where the balance of apoptosis processes could shift to metastasis. In some cancers, the protein enhances apoptosis through mitochondrial pathways, and disruption of survival signaling. There have been observations to suggest a correlation between tumor progression and human lumphoid disease as well because of an accumulation of galectin-7 with no expression detected in normal tissue where it is normally found. Galectin-7 has been mainly studies under carcinoma cancers and have shown how they are associated with a decrease in galectin-7 expression however, squamous epithelial and mucous tumors still express higher galectin-7 levels than normal tissues in cancers having to do with the head and neck. This displays how over expression and under expression of galectin-7 can be cause for concern when it comes to developing cancers in the body. The protein has also been found to down regulate, meaning the tumor cells have a reduced expression of galectin-7, producing an association, not necessarily causation, to poor tumor differentiation.
France's "February Revolution" of 1848, was the first of the Revolutions of 1848. The events of the revolution led to the end of the 1830–1848 Orleans Monarchy and led to the creation of the Second Republic. The Revolution of 1830, part of a wave of similar regime changes across Europe, had put an end to the monarchy of the Bourbon Restoration and installed a more liberal constitutional monarchy under the Orleans dynasty governed predominantly by Guizot's conservative-liberal center-right and Thiers' progressive-liberal center-left. But to the left of the dynastic parties, the monarchy was criticized by Republicans (a mixture of Radicals and socialists) for being insufficiently democratic: its electoral system was based on a narrow, privileged electorate of property owners and therefore excluded workers. During the 1840s several petitions requesting electoral reform (universal manhood suffrage) had been issued by the National Guard but had been rejected by both of the main dynastic parties. Political meetings dedicated to this issue were banned by the government, and electoral reformers therefore bypassed the ban by holding a series of 'banquets' (1847–1848), events where the political debate was disguised as dinner speeches. This movement began overseen by Odilon Barrot's moderate center-left liberal critics of Guizot's conservative government but took on a life of its own after 1846 when the economic crisis encouraged ordinary workers to demand a say over the government.
Elton John plays the final UK concert of his farewell tour at Glastonbury 2023, headlining the Pyramid Stage on the festival's final day. 26 June A two-year BBC investigation into the 1993 murder of Stephen Lawrence identifies a sixth suspect who was not charged at the time and is now deceased. Banking giant HSBC announces that it will vacate its 45-storey tower at 8 Canada Square in Canary Wharf and establish a smaller headquarters, possibly in the City of London, when its current lease expires in 2027. The move is attributed to an increase in remote work and less need for in-person office work. Prince William and Geri Horner announce the launch of Homewards, a five-year project aimed at reducing the number of homeless people in the UK. The National Cancer Research Institute announces that it will be closing, amid concerns over its funding. 27 June Boots announces plans to close 300 of its outlets over the next years, saying it will close stores in close proximity to other branches. A report compiled by the Independent Commission for Equity in Cricket (ICEC) says racism, sexism, classism and elitism are "widespread" in English and Welsh cricket. 28 June Daniel Korski withdraws as the Conservative Party's candidate for the 2024 London mayoral election after being accused of groping by novelist and TV producer Daisy Goodwin. A BBC News investigation finds that paedophiles are using Stable Diffusion, a piece of artificial intelligence software, to create lifelike images of child sexual abuse, which are then being distributed through platforms such as Patreon.
There are two mass spectrometry-based methods currently used for protein profiling. The more established and widespread method uses high resolution, two-dimensional electrophoresis to separate proteins from different samples in parallel, followed by selection and staining of differentially expressed proteins to be identified by mass spectrometry. Despite the advances in 2-DE and its maturity, it has its limits as well. The central concern is the inability to resolve all the proteins within a sample, given their dramatic range in expression level and differing properties. The combination of pore size, and protein charge, size and shape can greatly determine migration rate which leads to other complications. The second quantitative approach uses stable isotope tags to differentially label proteins from two different complex mixtures. Here, the proteins within a complex mixture are labeled isotopically first, and then digested to yield labeled peptides. The labeled mixtures are then combined, the peptides separated by multidimensional liquid chromatography and analyzed by tandem mass spectrometry. Isotope coded affinity tag (ICAT) reagents are the widely used isotope tags. In this method, the cysteine residues of proteins get covalently attached to the ICAT reagent, thereby reducing the complexity of the mixtures omitting the non-cysteine residues. Quantitative proteomics using stable isotopic tagging is an increasingly useful tool in modern development.
Sources: en.wikipedia.org
Reverse-phase HPLC with ultraviolet detection at 214 nm is common. Mass spectrometry is used to confirm molecular identity and detect modifications. Immunoassays exist but may not distinguish the intact peptide from fragments.
The lyophilized powder is usually stored at -20 °C or below. Dissolved solutions are less stable and should be prepared fresh when possible. Freeze-thaw cycling can reduce integrity.
It lacks aromatic residues, so it does not absorb strongly at 280 nm. Its negative charge and hydrophilic nature can affect chromatographic retention. These properties require method development for reliable separation.
Its sequence corresponds to the amino-terminal portion of prothymosin alpha, a larger protein present in many cell types. The isolated 28-residue peptide is a fragment of that protein rather than a separately encoded molecule, and laboratory material is produced by synthesis.